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Summary 
The production of class-switched antibodies, particularly immunoglobulin (Ig)G1 and IgE, oc- 
curs efficiently in T cell receptor (TCP,)ot-/- mice that are congenitally devoid of or/J3 T cells. 
This finding runs counter to a wealth of data indicating that IgG1 and IgE synthesis are largely 
dependent on the collaboration between B and ot/[3 T  cells.  Furthermore, many of the anti- 
bodies synthesized in TCRot-/-  mice are reactive to a similar spectrum of self-antigens as 
that targeted by autoantibodies characterizing human systemic lupus erythematosus (SLE). SLE, 
too, is most commonly regarded as an ot/[3 T  cell-mediated condition. To distinguish whether 
the development of autoantibodies in TCP,  ot-/-  mice is due to an intrinsic de-regulation of 
B  cells,  or to  a heretofore poorly characterized collaboration between B  and "non-or/J3 T" 
cells, the phenotype has been reconstituted by transfer of  various populations of  B and non-or/J3 
T  cells including cloned ~//8 T  cells derived from TCRcx-/-  mice, to severe combined im- 
munodeficient (SCID) mice. The results estabhsh that the reproducible production of IgG1 
(including autoantibodies) is a product of non-a/j3 T  cell help that can be provided by "y/8 T 
cells. This type of  B-T collaboration sustains the production of germinal centers, lymphoid fol- 
licles that ordinarily are anatomical signatures of  or/J3 T-B cell collaboration. Thus, non-or/J3 T 
cell help may drive Ig synthesis  and autoreactivity under various circumstances, especially in 
cases of or/J3 T  cell immunodeficiency. 
T 
he production oflgG and IgE antibodies in the mouse 
is regarded as largely dependent on CD4 + or/f3  + Th 
cells (1). Such T cells provide cytokines to B cells with which 
they enter into antigen-specific, TCR-mediated cognate in- 
teractions  (2).  The  generation  of antibodies  is  associated 
with the development of  specific anatomical structures, ger- 
minal centers (GCs) 1, in which a significant fraction of Ig 
class switching and most somatic mutations occur (3, 4). T 
cells seem to be required for these processes because anti- 
body production (particularly IgG1)  (5, 6) and GC forma- 
tion (7, 8)  are reduced in congenital athyrnic nu/nu  mice, 
but return to normal levels after adoptive transfer of T  cells 
(8-10).  Likewise,  SCID  mice receiving highly purified B 
cells  failed to develop GCs,  whereas  GCs were inducible 
after transfer of B and CD4 + T  cells (11). 
1Abbreviations used in  this paper: ANA, antinuclear antibody; CD40L, 
CD40 ligand; GC, germinal  center; PNA, peanut agglutinin. 
Despite  these  data,  several  observations raise  questions 
about the T  cell dependence of GC formation. In particu- 
lar,  whereas GC formation is clearly less efticient in nu/nu 
mice, it nonetheless occurs (7, 8,  10,  11), and in some col- 
onies of nu/nu  mice, IgG synthesis can be comparable to 
normal (12). This may be because the nu/nu  mutation (13) 
is pleiotropic, with variable effects on 0r  T  cells and "y/8 
T cells. Thus, whereas it is clear that CD4 § ot/[3 T cells en- 
hance  GC formation, it is unclear whether GC develop- 
ment in the nu/nu  mouse is wholly supported by the small 
number of CD4 + ot/[3 T  cells that "leak through" (11),  or 
by other T  cells. 
Germane  to  this  issue  are  recent  data  showing  that 
TCR.ot-/-  mice, congenitally devoid ofo~/[3 T  cells, com- 
monly display serum IgG and IgE levels comparable to or 
higher than those of or/f3 T  cell-bearing littermates  (14), 
and that among nonimmunized mice, more GCs develop 
than in TCRot+/-  littermates (Dianda, L., A. Judge, W. 
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manuscript submitted for publication).  These data suggest a 
reasonably  efficient  pathway  of B  cell  maturation  and  Ig 
production that cannot involve o~/[3 T  cells,  and for which 
a paradigm is currently lacking.  Furthermore,  many of the 
antibodies in TCRci-/-  mice are reactive to self-antigens 
such as double stranded DNA  (dsDNA) and small ribonu- 
cleoprotein particles (snRNPs), that are commonly the tar- 
gets of autoantibodies in patients with SLE (16). This raises 
the issue of whether or not the initiation  of SLE is always 
truly dependent on CD4 + Ix/J3 + Th cells,  as has most often 
been concluded. In fact, there are numerous reports of au- 
toantibodies produced in ci/[3 T  cell-immunodeficient in- 
dividuals,  such  as those with  AIDS  (17).  The potential  to 
develop autoantibodies  in the absence of ci/[3 T  cells  em- 
phasizes  the  need  to  understand  better  the  processes  of 
non-oL/[3 T  cell-dependent  B  cell  differentiation  and  GC 
formation. 
To determine the mechanism orb  cell maturation in the 
absence  of oc/[3 T  cells,  an initial  question  is whether  the 
phenotype is B  cell autonomous.  For example, B  cells  that 
develop in TCRc~-/-  mice may lack downregulatory ef- 
fects of c~/l~ T  cells, and therefore may be intrinsically hyper- 
active.  This  concept is analogous to that invoked for cases 
of human  common variable  immunodeficiency,  in which 
B  cell activation is enhanced by depletion of CD8 + 0r  T 
cells (1). Such a scenario may also explain the predisposition 
to SLE-like autoimmunity shown by NZBxNZW.F1 mice, 
since  aspects  of that  disease  can be  reconstituted  in SCID 
mice by the adoptive transfer of B cells alone (18). Alterna- 
tively,  the  TCR0t-/-  mouse  may  constitute  a  prime 
example  of T  cell  help  provided  by  "non-oc/[3  T  cells." 
Suggestive of this,  IL-4 production was detected in super- 
natants ofT cells  from TCRc~-/-  mice, and coculture of 
such T  cells  in the presence  of pokeweed mitogen (which 
enhances B-T interactions)  strongly stimulated B  cell pro- 
liferation  (14).  However, these experiments  did not deter- 
mine the precise cellular requirements for the "TCRoc-/- 
phenotype," collectively, the c~/13 T  cell-independent pro- 
duction  of class-switched  Igs  (commonly autoantibodies), 
and the formation of GCs. 
Thus,  to  define  the  cells  required  for generation  of the 
TCRc~-/-  phenotype,  an adoptive transfer approach has 
been employed, whereby various combinations orB cells and 
TCRa-/--derived  non-a/13  T  cells,  including  cloned 
~//8 T  cells,  have been transferred  to lymphocyte-deficient 
SCID mice.  Those studies,  described here,  indicate  that B 
cell maturation  characteristic  of TCR(x-/-  mice can re- 
producibly  be  established  and  maintained  outside  of the 
TCRoc-/-  animal, but that it requires B cells plus non-ec/[3 
T  cells.  From the data presented,  it is possible to conclude 
that  non-e~/[~  T  cells,  including ~/B  T  cells,  can  help  B 
cells,  a finding that may be highly relevant  to instances  of 
autoimmunity,  especially in cases of cx/13 T  cell immuno- 
deficiency.  The  potential  differences  between  help  pro- 
vided by 0t/J3 T  cells and non-ot/13 T  cells,  and the possible 
relevance  of this  to  normal  animal  physiology,  are  dis- 
cussed. 
Materials and Methods 
Mice.  All  mice  used  in  this  study  were  bred  and  main- 
tained  in  our  specific  pathogen-free  animal  facilities  at  Yale 
University. TCRc~-/-  mice were generated by gene targeting 
(19).  CB17.SCID,  C57BL/6.SCID,  NOD.SCID,  TCR[3-/- 
and TCRS-/-  mice were originally obtained from The Jackson 
Laboratory (Bar Harbor, ME); TCR(13￿  mice were gen- 
erated  locally.  TCRec-/-  mice  used  for transfers  were  back- 
crossed either five generations to BALB/c (H-2  a) or two genera- 
tions to 129 (H-2b), and selected on the basis of homozygosity at 
the MHC. 
mAbs.  The following mAbs were purchased from PharMin- 
sen  (San Diego,  CA):  PE-conjugated  anti-CD3  (2Cll),  anti- 
TCR',//8  (GL3),  anti-CD8  (53-6.7);  FITC-conjugated  anti- 
TCRoc/~  (H57),  anti-CD4  (RM4-5),  and  biotin-conjugated 
anti-CD90  (anti-Thyl.2;  53-2.1),  anti-CD45R  (B220,  RA3- 
6B2), and anti-CD40 ligand (CD40L, MRL). Hybridoma culture 
supernatants  were  either  maintained  in  this  laboratory  (2Cll, 
H57,  and  GL3)  or  kindly  provided  by  Dr.  C.  Janeway,  Jr., 
Howard Hughes Medical  Institute,  Yale University (2.4G2,  anti- 
Fc receptor; 212A.1, anti-I-Ab/a). 
Depletion of T Cells.  Total splenocytes from TCRcl-/-  mice 
were largely depleted of T cells by negative  selection  using mag- 
netic beads.  Splenocytes  were incubated with mAbs 2Cll, H57, 
and GL3 (all hamster IgG) for 30 rain on ice. After washing,  the 
cells were incubated with goat anti-hamster IgG-conjugated mag- 
netic beads (Advanced Magnetics, Inc., Cambridge,  MA) for 1 h on 
ice with gentle agitation.  T-depleted splenocytes  were then sepa- 
rated using a magnetic plate (two cycles). All mAbs used were su- 
pernatants  that had been previously titered.  T  cell depletion was 
evaluated  by FACS  |  analysis (Becton Dickinson & Co., Moun- 
tain View, CA). 
Cell Staining and FACS  ~ Analysis.  Single cell suspensions  (10" 
cells/ml) were incubated with PE- or FITC-conjugated antibodies 
at pretitered  dilutions on ice for 30 min, followed by washing three 
times with PBS plus 1% FCS and 0.02% sodium azide. When bi- 
otin-conjugated mAbs were used,  cells were incubated with flu- 
orescence-conjugated streptavidin.  Stained cells were fixed in PBS 
containing  1% paraformaldehyde and  analyzed  on a FACScan  | 
(Becton Dickinson &  Co.).  Dead and nonlymphoid cells were 
excluded from analysis by selective  gating based  on forward and 
side scatter. 
Establishment of y~8 T Cell Clones.  The detailed  isolation  and 
characterization  of'y/B T  cell clones will be described  elsewhere 
(Wen, L. et al., manuscript in preparation).  In brief,  splenocytes 
(2  ￿  106) from TCRcx-/-  mice were cultured in Click's me- 
dium  containing 5  U/ml  IL-2  (supematant  of EL4),  5%  heat- 
inactivated  FCS  (Hyclone Laboratories,  Inc.,  Logan, UT),  and 
antibiotics  (GIBCO BRL, Gaithersburg,  MD). Clone G5 was de- 
rived  from limiting dilution performed in 96-well microculture 
plates at a concentration of < 1 cell/well.  For maximum expres- 
sion of CD40L, cloned ",//8 T  cells were activated  by PMA (10 
ng/ml) and ionomycin (1  p,M) (GIBCO BRL) for 6 h.  Cytokine 
mRNA profiles of the ~//8 T  cell clone were determined by re- 
verse transcription  (RT)-PCR (20). 
Adoptive Cell Transfer and Cell Tracing.  15  X  106  splenocytes 
from TCRer  mice (3-5 too-old) were injected intravenously 
into CB17.SCID, C57BL/6.SCID, and NOD.SCID mice (5-8- 
wk-old). A T-depleted cell population (10  ￿  10 6)  derived from 
spleens of TCRot-/-  mice was also used in the transfer experi- 
ments.  To investigate  the kinetics  of GC formation, SCID mice 
reconstituted with splenocytes from TCRo~-/-  mice were killed 
at different time points after reconstitution. Direct evidence of re- 
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cent dye DiI (Molecular Probes, Inc., Eugene, OR), at 37~  for 
30 rnin before reconstitution. Transferred cells that labeled with 
the dye were easily observed on frozen sections by fluorescence 
microscopy. To investigate the role ofy/~ T  cells, reconstitution 
was also performed using 5  ￿  10  ~ cloned ~//~ T  cells (see above) 
together with 10 X  106 splenocytes derived from TCIL(J~X~)-/- 
mice (8-10-wk-old) as a source of B cells that lacks any type ofT 
cell. 
Quantitation oflg Levels.  SCID mice were bled and individual 
serum samples collected every 2  wk after reconstitution. Total 
levels of serum IgM, IgG1, IgG2a, IgG2b, [gG3, and IgA were 
determined  by  ELISA.  Briefly, 96-well  ELISA plates  (Falcon) 
were coated with goat anti-mouse Ig (H + L chain) (Southern Bio- 
technology Associates Inc., Birmingham, AL) overnight at 4~ 
(5 p,g/ml) in sodium carbonate buffer (pH 9.6). After three washes 
in  PBS containing 0.1% Tween 20  (washing buffer), the plates 
were blocked with 1% BSA in PBS (blocking buffer) for 1 h  at 
37~  Serum samples diluted in blocking buffer were added and 
incubated for 2 h at 37~  After three washes with washing buf- 
fer, the plates were then incubated for 2  h  with alkaline phos- 
phatase  (AP)-labeled goat anti-mouse Ig isotype antibodies (South- 
em  Biotechnology  Associates  Inc.)  diluted  1:500  in  blocking 
buffer. After washing, the plates were developed with p-nitrophe- 
nyl phosphate (1  mg/ml) (Sigma Chemical Co., St. Louis, MO) 
as  substrate.  The  reaction was  stopped by  1  N  NaOH.  Plates 
were read on a microplate reader (Titertek) at OD 405. 
Detection of Autoantibodies.  Antinuclear (ANA) and anti-DNA 
(dsDNA) antibodies were detected by indirect immunofluores- 
cence using HEp-2 cells (Quidel, San Diego, CA) and Cfithidia 
luciliae (Chemicon, Temecula, CA) as antigens, respectively, and 
FlTC-conjugated goat anti-mouse  IgG (Sigma Chemical Co.). 
Anti-snRNP antibodies were detected by ELISA (21). 
Detection of GCs.  GC formation was examined in the spleens 
of TCRet-/-  mice and reconstituted SCID mice using immu- 
nohistochemistry, as  reported  (22).  Briefly, 6-g+m-thick frozen 
spleen sections were rehydrated in PBS followed by treatment in 
PBS  containing 0.15%  H202  to inhibit endogenous peroxidase 
activity. The sections were then blocked with rat IgG (100 ~g/ml) 
for 30 rain to prevent nonspecific binding. T and B lymphocytes 
in GCs were identified by biotin-labeled mAb to CD90 (Thyt.2, 
53-2.1)  and CD45P,  (B220,  RA3-6B2),  respectively (PharMin- 
gen)  followed  by  Streptavidin-conjugated with  AP  (Southern 
Biotechnotogy  Associates  Inc.).  Sections  were  then  incubated 
with  substrate  Napthol  AS-MX  phosphate/Fast blue  BB  base 
(Sigma Chemical Co.). GC B  cells, characterized by binding of 
peanut agglutinin (PNA), were identified with PNA conjugated to 
horseradish peroxidase (E-Y. Laboratories, Inc., San Mateo, CA). 
Staining was visualized using the substrate 3-amino-9-ethyl-car- 
bazole (Sigma Chemical Co.). 
Histological Examination.  Livers, kidneys, intestines, and lungs 
from reconstituted SCID mice were fixed in 10% buffered forma- 
lin, paraffin-embedded, and stained with hematoxylin and eosin. 
The sections were examined microscopically for lymphocyte in- 
filtration to evaluate the presence of GVHD. 
Results 
Phenotypic Characterization  of TCRc~-/-  Splenocytes  Used 
for Reconstitution.  Three  scenarios could explain the basis 
for B  cell maturation,  Ig class switching, and autoreactivity 
seen in the absence ofe~/[3 T  cells (the TCRo~-/-  pheno- 
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type): (a)  the TCRo~-/-  phenotype was  an autonomous 
property ofTCP,~x-/-  B  cells that could be transferred to 
another animal using TCP, c~-/-  B  cells alone; (b) it was a 
property of cell-cell interactions in TCILo~-/-  mice that 
could be transferred to another animal using TCRce-/- 
splenocytes;  and  (c)  it  was  the  product  of complex  lym- 
phoid-stromal interactions unique to the TCP,~x-/-  mouse 
that could not be transferred to another animal. To distin- 
guish  among  these  possibilities, TCR0~-/-  splenocytes 
were adoptively transferred to SCID mice that were subse- 
quently evaluated for Ig class switching, autoantibody pro- 
duction, and GC formation. For comparison, we examined 
SCID mice that were either mock reconstituted or recon- 
stituted with T-depleted TC1Lc~-/-  splenocytes. 
TCRo~-/-  splenocytes  used  for  transfer  were  ~15% 
CD3 +  and  >60% B220 +  (Fig.  1  a), in general agreement 
with  previous  data  (19,  23).  A  small subset  of cells were 
B220 + and CD3 +, also discussed recently (24). SCID mice 
analyzed 6 wk after engraftment with TC1L~x-/-  splenocytes 
displayed a FACS  |  profile that was almost indistinguishable 
from the donor inoculum (Fig. 1 b). By contrast, essentially 
no  CD3 +  or B220 +  cells were  detected in the  spleens of 
SCID mice mock reconstituted with PBS alone (Fig. 1 c). 
SCID  mice that received T-depleted TCR.e~-/-  spleno- 
cytes  contained  essentially no  CD3 +  cells;  the  stably en- 
grafted population was "~100% B220 + (Fig. 1 d). 
No  evidence of overt GVHD  was found after compre- 
hensive pathological investigation of several organs in  the 
adoptively transferred mice. Other signs of GVHD, such as 
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Figure  1.  T  (CD3*) and  B  (B220  +)  profiles of splenocytes from 
TCP,0L--/--  mice and SCID mice, 6 wk after reconstitution with cells 
from TCk0t-/-  mice. (a) TCILcx-/- splenocytes used for adoptive 
transfer; (b) spleen cells  from SCID mouse reconstituted with TCRe~-/- 
splenocytes; (c) spleen cells from SCID mouse reconstituted with PBS; 
and (d) spleen cells from SCID mouse reconstituted with TCP,~x-/- 
splenocytes predepleted of T cells. Y-axis, anti-CD3; x-axis, anti-B220. 
Percentages of cells in each quadrant are indicated by the numbers in the 
top comer of each panel. diarrhea and skin lesions, were also  not evident (data  not 
shown). Since GVHD usually involves host B  cells, which 
are absent in SCID recipient mice, this finding is not sur- 
prising.  This issue is discussed  further below. 
Reconstitution of  lg Production in SCID Mice.  Reconstituted 
SCID mice were assessed for serum Ig production. Circu- 
lating levels of Ig of all isotypes were measured every 2 wk 
after reconstitution until the experiments were terminated 
(usually at 20 wk after transfer). Igs of all isotypes examined 
could  be  readily  detected  in  CB17.SCID  mice  (H-2  a) 
within  2  wk  after reconstitution with  TCRer  lym- 
phocytes (H-2  b) (Fig. 2 A). Similarly, Igs of all isotypes ex- 
amined were detectable in NOD.SCID  mice (KdDbI-Ag  7) 
reconstituted with TCRc~-/-  lymphocytes (H-2  b) (Table 
1). To examine whether Ig production depended on mis- 
match of  donor and recipient MHC, C57BL/6.SCID (H-2  b) 
and CB17.SCID  (H-2  a) mice were each used as recipients 
for splenocytes from H-2  b and H-2  a TCR(x-/-  donors, 
respectively. In each case, class-switched antibody produc- 
tion was  observed (Fig.  2,  B  and  C),  although the levels 
were usually lower than in MHC-mismatched reconstitu- 
tions (Table 2 and discussed  below). 
By contrast, four of five mice that received T-depleted 
donor splenocytes produced exclusively IgM. When class- 
switched Ig levels were converted to micrograms per milli- 
liter,  the  results  (Table 2)  confirmed that  mice  receiving 
TCRc~-/-  splenocytes invariably supported the synthesis 
of class-switched Ig, whereas this only occurred in one of 
five mice  receiving T-depleted cells.  As  expected, no  Ig 
was  detected in sera  from SCID mice mock reconstituted 
with PBS (Table 1). 
Reconstitution of Spontaneous Autoantibody Production in SCID 
Mice.  Ig  production  in  TCR(x-/-  mice  is  commonly 
characterized by autoreactivity (14).  The level of autoanti- 
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Figure  2.  lg production, detected by ELISA in the sera 
(diluted  1:100)  of  SCID  mice  reconstituted  with 
TCRc~-/-  splenocytes (A-C), and in SCID mice recon- 
stituted with TCR~-/-  splenocytes predepleted of T  cells 
(D), detected at 2, 5, 8, 10, 13, and 18 wk after transfer. Table 1.  Reconstitution of TCRel- /-  Phenotype in SCID 
Mice* 
Class 
IgM  switching  GC  ANA 
CB17.SCID (H-2  a) 
reconstituted with: 
TCRc~-/-  splenocytes  (H-2  b)  10/10~  10/10~  10/10~  5/1011 
B cells (H-2  b)  2/2  0/2  0/2  1/2 
TCRci-/-  splenocytes  (H-2  a)  4/4  4/4  4/4  3/4 
PBS  0/2  0/2  0/2  0/2 
B6.SCID (H-2  b) 
reconstituted with: 
TCRo~-/-  splenocytes  (H-2  b)  6/6  6/6  6/6  6/6 
PBS  0/2  0/2  0/2  0/2 
NOD.SCID (H-2g7)￿82 
reconstituted with: 
TCRoL-/- splenocytes  (H-2  b)  6/6  6/6  4/6  ND 
B cells (H-2  b)  3/3  1/3  0/3  ND 
PBS  0/3  0/3  0/3  ND 
*SCID mace (5-8 wk of age) on different backgrounds were reconsti- 
tuted with different lymphocytes populations from TCRo~-/- mice. 
r  IgM and class-switched Igs were detected by ELISA. 
~GCs were detected on sections of spleens from the various SCID re- 
cipients. 
lIANA autoantibodies were detected using HEp-2 cells as substrate. 
￿82  haplotype of NOD mice is KaDb/I-Ag  7. 
bodies was therefore examined in the sera of reconstituted 
SCID mice. 70% (14/20)  of SCID mice reconstituted with 
total splenocytes produced IgG ANA (Table 1). Two major 
ANA  staining  patterns  were  observed,  homogeneous  and 
speckled,  both  of which  are  commonly produced  by au- 
toantibodies from MRL/lpr mice (data not shown). More- 
over, several TCRoL-/-  reconstituted SCID mice had ANA 
titers  as  significant as those  of MRL/lpr  mice  (1:1,280- 
1:2,560, data not shown). Whereas total Igs could be easily 
detected by 2  wk post-cell transfer,  ANA was not readily 
detectable  until  3-4  wk.  Again,  ANA were  produced  in 
both MHC-matched and -mismatched transfers (Table  1). 
Anti-dsDNA was assayed by immunofluorescence against 
C.  luciliae, and  anti-snRNP  antibodies  assayed by ELISA. 
3/14  (21%)  of ANA-positive SCID sera were also positive 
for  anti-dsDNA  antibodies,  albeit  at  low  titer,  and  anti- 
snRNP  autoantibodies  were  present  in  4/14  (29%)  of 
ANA-positive  SCID  sera  tested  (data  not  shown).  One 
SCID  mouse  reconstituted  with  T-depleted  splenocytes 
also  developed  detectable  ANA,  but  exclusively  of IgM 
isotype (Table  1). 
GC Formation in SCID Mice Reconstituted with TCRee-~- 
Cells.  Although GCs are considered a hallmark of or/J3 T 
cell  help  (3,  4),  many of them can be found in nonmanipu- 
lated TCRot-/-  mice  (15).  GCs were also detectable  in 
100% of CB17.SCID mice and B6.SCID mice reconstituted 
with  total  splenocytes  from TCRot-/-  mice  (n  =  20), 
and in 67%  (four of six)  of NOD.SCID mice likewise  re- 
constituted (Table  1). The GCs were easily seen in the sec- 
tions of spleens  (Fig.  3,  a,  b, e, and f): analysis by staining 
serial  sections  with  PNA  and  B220,  or  PNA  and  anti- 
CD90 (anti-Thyl.2), revealed a characteristic GC pattern in 
which B220 +  cells  formed  a  mantle  zone,  bordering  the 
PNA  + area (Fig. 3, b and f), whereas T  cells (CD90 +) were 
offset to one side (Fig. 3, a and e), toward the central arteri- 
ole.  Consistent with the TCRtx-/-  mutation,  the T  cell 
zones were  usually less  densely populated  than  the  corre- 
sponding regions of  immunized BALB/c mice or TCRot+/- 
littermates (data not shown). When examined blind ofgen- 
otype, GCs detected in reconstituted SCID mice could not 
be distinguished from those in TCRcx-/-  mice (data not 
shown).  By contrast,  GCs were  absent  in  SCID mice re- 
constituted  with  either  PBS,  or  T-depleted  splenocytes 
Table 2.  IgG Serum Levels in SCID Mice Receiving Splenocytes  from TCRol- /-  Mice 
Number  IgG2a  IgG2a  IgG1  IgG1 
of mice  >25 txg/ml  >50 txg/ml  >8 I~g/ml  >30 I~g/ml 
CB17.SCID (H-2  a) 
reconstituted with: 
TCR~x -  / -: total splenocytes  (H-2  b)  10  + * 
TCRIx-/-:  T-depleted cells (H-2  b)  2  - 
TCRcl-/-:  total splenocytes  (H-2  a)  4  + 
PBS  2  - 
B6.SCID (H-2  b) 
reconstituted with: 
TCRo~-/-: total splenocytes  (H-2  b)  6  + 
PBS  2  - 
+  +  + 
--  -4-  -- 
+ 
* (+) indicates complete concordance. 
2275  Wen et al. Figure 3.  GC formation in reconstituted SCID mice. GCs, detected with PNA, which stained red-brown, were found in SCID mice reconstituted 
with TCR.0t-/-  splenocytes (a, b, e, and  f); but not in SCID mice reconstituted with TCIkot-/-  splenocytes predepleted of T  cells (c, d, and g). Char- 
acteristic GC patterns are shown at higher power (5(100)  (e and f).  T  cell zones around arterioles were detected in a and e with anti-Thyl.2, which 
stained blue. Primary follicular B cell areas were detected in b, d,f, and g with anti-B220 (blue).  Originally: (a-d)  X40; (e-g)  X 100. 
2276  Nonconventional T  Cell Help (Table  1).  In the latter case,  areas of B220 +  cells could be 
detected in the spleens (Fig. 3, d and g), but neither PNA + 
areas, nor CD90 + cells were ever detected (Fig. 3, c, d, and 
g).  This is consistent with previous observations that B  ceUs 
alone cannot support GC formation (11). 
Kinetics of PNA + GC Formation.  The formation of  splenic 
GCs in conventional mice ordinarily occurs within 4-14 d 
after primary immunization (7, 25). After secondary immu- 
nization, it may occur as early as day 2 (7, 26). To examine the 
kinetics of GC formation in recipient SCID mice, animals 
from a  group of SCID  mice transferred with TCILet-/- 
splenocytes were killed at days 2, 6,  12,  and 20 after trans- 
fer. To trace the transferred cells, splenocytes were labeled 
with the lipophilic fluorescent dye, DiI, for 30 min before the 
transfer. This tracing experiment showed that reconstituted 
donor cells were clearly detectable as distinct anatomical ag- 
gregates by day 6  (Fig. 4  a). By day 12 after reconstitution, 
these cells were still observed, although the fluorescence was 
lighter (Fig. 4  c), probably because of decay of the dye, the 
death  of a  subset  of the  inoculum,  and/or  a  reduction  in 
cellular concentration of the dye in remaining viable cells as 
a  result of cell division. Interestingly, although B220 +  ag- 
gregates were revealed at day 6  (Fig. 4 b), PNA + GCs were 
not apparent until day 12 after reconstitution (Fig. 4  d). 
Figure 4.  Kinetics of GC formation. Splenocytes from TCRet-/- mice were labeled with DiI, before transfer to SCID mice, and subsequently de- 
tected as follicular areas on day 6 (a) and day 12 (c) after transfer. GCs double stained with PNA (red-brown) and anti-B220 (blue) were absent from spleen 
sections on day 6 after transfer (b), but were notable in sections from mice on day 12 after transfer (d). B cells were stained with anti-B220 (blue) (a-c) 
x40; (d) XlO0. 
2277  Wen et al. Figure 5.  FACS  |  profiles of ~//8 T cell clone G5. Cloned "//8 T cells 
(G5) were stained with PE-conjugated anti-CD4 (RM4-5) together with 
FITC-conjugated anti-TCR8 (GL3, a) or TCRI3 (H-57, b). (c) Expres- 
sion of CD40L  (MR1) on clone G5 6 h after activation (10 ng/ml of 
PMA plus 1 I~M ionomycin). Percentages of  cells in each quadrant are in- 
dicated by the numbers in the top comer of each panel. The cytokine 
profile of G5 was assessed  by RT-PCI:(, as shown in the ethidium bro- 
mide-stained gel (d). (Lane 1) 100-bp molecular weight marker; (lanes 2, 
and 3) amplification oflL-4 cDNA from G5 RNA (lane 2 is 1:2 dilution 
of lane 3 before loading); (lane 4) amplification of HPRT cDNA from 
G5 RNA; (lanes 5 and 6) attempted amplification of IFN-y and TNF[3 
cDNA, respectively,  from G5 R.NA. 
GC Formation Supported by 3'/8 T  Cells.  TCP,  a-/-  mice 
contain  two  types of T  cell: TCIL~x-13 +  and ~//5  T  cells. 
Either  or both  of these  may provide  help  to  B  cells  and 
support  GC  formation.  To  determine  which  population 
was  responsible,  cloned  TCRy/8 +  and  TCRa-I3 +  cell 
lines were derived for use in reconstitution experiments to- 
gether  with  B  cells from  TCR(I3￿  mice,  that  for 
genetic reasons cannot be contaminated with T  cells. This 
approach was  adopted because it proved difficult to  abso- 
lutely deplete TCRe~-/-  splenocytes of either just y/8  T 
cells  or  TCRcx-I3 +  cells.  Minor  contamination  by  either 
population  could  affect interpretation of long-term  adop- 
tive transfer. 
The growth ofTClLc~-13 + cell lines was too slow for trans- 
fer studies. However, it was possible to transfer a ~/5 T  cell 
clone,  G5  (see Materials and  Methods  and  a  detailed de- 
scription of which will be provided elsewhere) (Wen, L., F.S. 
Wong, M.J. Owen, and A.C. Hayday, manuscript in prepara- 
tion). G5 cells are TClLS(+)I3(-), CD4 + (Fig. 5, a and b). Al- 
most  half  the  cells  were  CD40L +  after  treatment  with 
PMA and ionomycin  (Fig. 5  c).  This result is important in 
assessing the capacity of G5 to support GC formation,  since 
GC  development  is  impaired  in  CD40L-/-  mice  (27, 
28).  Consistent with the phenotype of clone G5, and con- 
trary to our previous assessment (14), we have shown that a 
subset  of TCRct-/-  y/8  T  cells,  in  a  T  cell-enriched 
population,  stains  positive  for  CD40L,  directly  ex  vivo. 
The cytokine profile of G5 could be classified as Th2,  since 
the cells expressed IL-4 mRNA  (Fig. 5  d, lanes 2  and 3), but 
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Figure  6.  GC  formation  sup- 
ported by "y/8 T cells. GCs, detected 
with PNA,  in SCID mice reconsti- 
tuted  with  G5  ~//8  T  cells and 
splenic  B  cells  derived  from 
TCR(I3XS)-/-  mice (a, c and d), 
and in SCID mice reconstituted  with 
TCRcx-/- splenocytes  (b). (a, b, and 
d) Double stained for B220 (blue); (c) 
double stained  with anti-CD90 (blue). 
(a-c) ￿  (d) ￿ no mR.NA for IFN-~/  or TNF[3 (Fig.  5  d, lanes 5 and  6. 
Lane 4 shows amplification of the HPR.T transcript cDNA, 
performed as a positive control for the PCR reaction). The 
capacity  to  amplify  IFN-~/  and  TNF[3  transcripts  was 
shown by a parallel analysis of Thl phenotype clones (data 
not shown). 
All mice  (n  =  3)  receiving G5 plus B  cells from TCR 
([3￿  mice examined after 6 wk scored positive for 
splenic GCs (Fig. 6); no GCs were detected in either mice 
(n =  3) receiving only B cells from TCR([3 X 5)-/-  mice 
or PBS  (n  =  3). The general architecture of the GCs ap- 
peared normal: PNA(+) clusters of cells (brown) rosetted by 
a mantle of B220(+), PNA(-) B cells (blue)  (Pig. 6 a). The 
GCs were commonly considerably smaller than those de- 
veloping in mice that received total splenocytes (Fig.  6 b). 
1Leasons for this are considered in the Discussion, but one 
factor may be relatively poor engraftment of the ~//8 T  cell 
clone after 6  wk.  Staining for CD90  (blue,  Fig.  6  c)  de- 
tected T  cells in the appropriate sites (offset to one side of 
the PNA(+) clusters (brown), denoted with a dotted line), 
but the numbers were small. The y/8 T  cell-supported GCs 
are shown at higher magnification in Fig. 6 d, where PNA(+) 
cells  (brown,  arrowed)  are  clearly visible  surrounded  by 
B220(+)  cells  (blue).  These  data  provide direct evidence 
that GC formation can be driven by "s  T  cells alone. 
Discussion 
The data presented here demonstrate a form ofT cell help 
for B  cells that does not require CD4 § et/~ T  cells.  Sple- 
nocytes from TCRot-/-  mice,  congenitally deficient in 
or/J3 T  cells, sustained the production of autoreactive Ig of 
multiple subclasses  upon adoptive transfer to lymphocyte- 
deficient SCID mice. In >90% of cases (24/26) there was 
accompanying formation of GCs,  anatomical features that 
signify T-B collaboration. Generation of the TCRot-/- 
phenotype requires some kind of T  cells, because the phe- 
notype was not observed when CD3 + cells were depleted 
from the transfer inoculum. Although transfers of spleno- 
cytes depleted of T  cells facilitated stable  engraftment of B 
cells, all but one of the recipient mice produced only IgM, 
and all failed to demonstrate GCs. 
TCR.ot-/-  splenocytes contain two types of potentially 
active T  cells:  "//8 T  cells  and TCIk0t-[3 +  cells  (23,  29). 
Our earlier work indicated that y/g T  cells could produce 
IL-4 (14), a finding since corroborated by studies of'y/8 re- 
sponses to various pathogens (30).  The evidence that such 
cells  can play a  causal  role in  a GC  reaction is presented 
here by the use ofa ~//5 T  cell clone with a Th2-type phe- 
notype to reconstitute a SCID mouse together with B cells 
from TCR([3XS)-/-  mice  (such B  cells  being uncon- 
taminated by T  cells).  Furthermore, recent data from our 
laboratories clearly demonstrate that B  cell maturation and 
GC formation can be induced by particular conditions in 
TCR[3-/-  mice (in which all T  cells are TCR'y/B+), but 
not in TCIL([3XB)-/- mice, in which there are no T  cells 
(Pao, W., L. Wen, A.L. Smith, and A.C. Hayday, unpub- 
lished observations). 
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Nonetheless, GCs in mice reconstituted with B ceils plus 
cloned ~//~ T cells are reproducibly smaller than those induced 
with total TC1kot-/- splenocytes, possibly for a few reasons. 
First,  in  the  absence  of other T  cells  (either TCR.ot-[3  + 
cells or polyclonal y/g T  cells), the engraftment of cloned 
"y/g T  cells and the kinetics of GC formation supported by 
those cells may be different to those in mice reconstituted 
with  total  splenocytes.  Second,  TCR.([3￿  B  cells 
may be less responsive to T  cell help than TCtkot-/-  B 
cells. Third, the kind of  help that ~//8 T cells provide may be 
qualitatively different from that given by ot/[3 T  cells.  Fi- 
nally, ~//~ T cells may simply not be as efficacious at support- 
ing the  GC reaction as are  other non-or/J3  T  cells, notably 
TCRet-[3  + T cells. Consistent with this, immunohistochem- 
ical studies of GCs of TCR0t-/-  mice show that the larger 
number ofT cells present are commonly TCRot-[3  + (15). 
The contribution ofTCP,  ot-[3 + cells to non-el/J3 T  cell 
help requires further elucidation. Although such cells have 
not yet been detected in normal mice or humans, there is 
no reason a priori to exclude their existence. Rearrange- 
ment of the TCR[3 chain genes is epistatic  to both TCR.et 
gene rearrangement and expression (31); thus, the status  of 
the TCIkot locus should not affect the capacity ofTClkot-[3  + 
cells to exit the thymus and enter the periphery. Possibly, 
both types of non-or/J3 T cell can provide B cell help, driv- 
ing the  GC reaction: ~//~  T  cells may help B  cells  under 
some circumstances, whereas TCR.ot-[3  + cells may provide 
help under others, according to the environmental status of 
the mouse. 
Recently, it has been shown that NK cells can provide B 
cell help (32, 33). However it is likely that non-or/J3 T  cells 
are the active inducers of the TCP,  mt-/-  phenotype for at 
least  three reasons.  First,  there is no compelling evidence 
that murine TCk(-)  cells with NK activity express CD3, 
and  mice  carrying  various  CD3  gene  disruptions,  e.g., 
CD3~-/-,  have unperturbed NK  activity (34).  Second, 
GC  formation  could  be  reconstituted  with  B  cells  plus 
cloned ~//~  T  cells  (discussed  above). Finally, CD4 + non- 
or/J3 T  cells were invariably detected in TCRo~-/-  GCs 
by immunohistochemistry (15). 
The defining difference between o~/[3 T  cells and non- 
ot/[3 T cells is the nature of the TCR, and by extrapolation, 
antigen specificity. Conventional or/J3 T-B help is medi- 
ated by the  TCR. in an antigen-specific fashion,  and the 
broad capacity of0t/[3 T  cells to recognize any one of myr- 
iad peptides presented by MHC  facilitates  skewing of the 
antibody repertoire toward the preeminent challenging an- 
tigen at any one time. Whether there is a subset of exoge- 
nous challenges to which non-or/J3 T  cells skew the B cell 
repertoire remains  to be  clarified.  However, the  efficient 
development of high titer, highly diverse, antigen-specific 
responses may be a unique property of or/J3 T  cells.  This 
would explain why TCILot-/-  mice fail to mount effica- 
cious  responses  against  a  number  of pathogens  (35,  36, 
Roberts, S.J., A.L. Smith, A.B. West, L. Wen, M.J.  Owen, 
and A.C. Hayday, manuscript submitted for publication), and 
why the  relative frequency of B  cells specific  for nominal 
T-dependent exogenous antigens, such as oxazalone, is not substantially increased by challenge of TCRa-/-  mice (our 
unpublished data). 
What  determines  the  repertoire  of B  cells  helped  by 
non-a/13  T  cells?  Polyclonal  B  cell  activation  may result 
from  the  recognition  of native,  class  II MHC  by ~//8  T 
cells  (38).  In numerous  phylogenetic  classes of animal,  in- 
cluding  various  birds  and  mammals,  ~//8  T  cells  interact 
with  other  cells  that  can  express  class  II  MHC,  such  as 
those of the intestinal epithelium  (39).  Specific interactions 
of 2#8  T  cells  with  various  activated  B  cells  have  been 
characterized  by  several  laboratories,  in  each  case  with  a 
seemingly different antigenic  basis for the interaction  (40- 
42). Alternatively, and not mutually exclusively, TCRot-[3 + 
cells may recognize  activated B  cells either through  MHC 
class  II  molecules  and/or  via  endogenous  superantigens, 
such as viral proteins  (43).  It is likewise possible that adop- 
tively transferred  non-or/13  T  cells are in part activated by 
MHC  mismatches, since an apparent low level reactivity of 
non-c~/[3  T  cells  to  polymorphisms  at  nonclassical  MHC 
loci  was recently  reported  (44).  Indeed,  the  highest levels 
of Ig synthesis were  sustained  in mice in which  there  was 
obvious  genetic  mismatch  between  graft  and  host.  How- 
ever,  since  there  are  no  host  B  cells,  particularly  in 
NOD.SCID  mice,  the B  cell activation documented  here 
is not  explained  by a  conventional  GVHD,  in  which  the 
host B  cells expand in response to their recognition by do- 
nor T  cells (45). 
Alternatively,  the  antibody-antigen  specificities  seen  in 
TCRcx-/-  mice may reflect antigen-specific responses of 
the non-e#[3  T  cells, either directly,  or as a result of cross- 
reactivity.  For example,  it has been demonstrated  that hu- 
man ",//8 T  cells can respond  to mycobacterial derivatives 
of thymidine  that might render such cells cross-reactive to 
DNA  (46).  It is possible,  therefore,  that pathogens  or au- 
toantigen aggregates are recognized directly by ",//8 T  cells, 
thereby  initiating  an  immune  response  that  includes  the 
help of self-reactive B  cells. 
In terms of other molecules involved, available data sug- 
gest that GC formation in mice is dependent  on the inter- 
action of CD40 on B  cells with CD40L on T  cells (47, 48). 
We  have  determined  that  ~10%  of TCR~/8 +  cells  in 
TCRot-/-  mice  express  either  CD28  or CD40L  (Wen, 
L.,  unpublished  data).  Moreover,  as  demonstrated  in  this 
paper,  the  expression  of CD40L  on  ~//8  T  cells  increases 
significandy after activation. Thus, these costimulatory mole- 
cules  may  also  be  required  to  generate  the  TCR(x-/- 
phenotype. 
Irrespective of the precise mechanisms involved in T-B 
interactions,  the data presented here indicate that there is a 
T  cell-dependent  pathway of B  cell maturation  that is not 
dependent on o#13 T  cells. These findings may explain why 
GC formation  (7,  10,  11)  and Ig class switching  (5,  6,  12) 
have  been  observed  in  a  low  percentage  of congenitally 
athymic  nu/nu  mice.  Although  these  mice  harbor  highly 
variable numbers  of CD4 + o#13  T  cells,  nu/nu  mice com- 
monly contain a significant number of~//8 T  cells (49). 
Non-or~f3  T  cell help may be physiologically relevant in 
normal  individuals.  Help  from  ~//8  T  and/or  TCRo~-I3 + 
cells  could  also  have  significant  ramifications  for the  pro- 
duction  of autoantibodies,  particularly,  in  cases  of o#13  T 
cell immunodeficiency. P,.ajagopalan et al. (50, 51) have re- 
ported that B  cell help in patients with SLE could be pro- 
vided  by ~//8  T  cells.  Whether  non-o#13  T  cells  provide 
help in other cases of human health or disease remains to be 
investigated.  Nevertheless,  it is striking that overt transfer- 
able autoreactivity can be shown in this paper to be the re- 
sult  of a  single  genetic  lesion  that  precludes  o#13  T  cell 
function. 
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